share_log

Addex Therapeutics analyst ratings

Addex Therapeuticsのアナリスト評価

Benzinga Analyst Ratings ·  2022/05/31 06:28
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
05/31/2022 307.61% HC Wainwright & Co. $21 → $15 Maintains Buy
02/11/2022 470.65% HC Wainwright & Co. $28 → $21 Maintains Buy
04/21/2021 660.87% HC Wainwright & Co. → $28 Initiates Coverage On → Buy

Addex Therapeutics Questions & Answers

What is the target price for Addex Therapeutics (ADXN)?

The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on May 31, 2022. The analyst firm set a price target for $15.00 expecting ADXN to rise to within 12 months (a possible 307.61% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Addex Therapeutics (ADXN)?

The latest analyst rating for Addex Therapeutics (NASDAQ: ADXN) was provided by HC Wainwright & Co., and Addex Therapeutics maintained their buy rating.

When is the next analyst rating going to be posted or updated for Addex Therapeutics (ADXN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addex Therapeutics was filed on May 31, 2022 so you should expect the next rating to be made available sometime around May 31, 2023.

Is the Analyst Rating Addex Therapeutics (ADXN) correct?

While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a maintained with a price target of $21.00 to $15.00. The current price Addex Therapeutics (ADXN) is trading at is $3.68, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする